202 related articles for article (PubMed ID: 21875767)
1. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer.
Awad S; Tan BH; Cui H; Bhalla A; Fearon KC; Parsons SL; Catton JA; Lobo DN
Clin Nutr; 2012 Feb; 31(1):74-7. PubMed ID: 21875767
[TBL] [Abstract][Full Text] [Related]
2. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer.
Yip C; Goh V; Davies A; Gossage J; Mitchell-Hay R; Hynes O; Maisey N; Ross P; Gaya A; Landau DB; Cook GJ; Griffin N; Mason R
Eur Radiol; 2014 May; 24(5):998-1005. PubMed ID: 24535076
[TBL] [Abstract][Full Text] [Related]
3. Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
Miyata H; Sugimura K; Motoori M; Fujiwara Y; Omori T; Yanagimoto Y; Ohue M; Yasui M; Miyoshi N; Tomokuni A; Akita H; Kobayashi S; Takahashi H; Yano M
Anticancer Res; 2017 Jun; 37(6):3053-3059. PubMed ID: 28551644
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
Prado CM; Lieffers JR; McCargar LJ; Reiman T; Sawyer MB; Martin L; Baracos VE
Lancet Oncol; 2008 Jul; 9(7):629-35. PubMed ID: 18539529
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study.
Bouchard DR; Dionne IJ; Brochu M
Obesity (Silver Spring); 2009 Nov; 17(11):2082-8. PubMed ID: 19373219
[TBL] [Abstract][Full Text] [Related]
7. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture.
Di Monaco M; Vallero F; Di Monaco R; Tappero R
Arch Gerontol Geriatr; 2011; 52(1):71-4. PubMed ID: 20207030
[TBL] [Abstract][Full Text] [Related]
9. [Aging and body composition: the sarcopenic obesity in Spain].
Gómez-Cabello A; Vicente Rodríguez G; Vila-Maldonado S; Casajús JA; Ara I
Nutr Hosp; 2012; 27(1):22-30. PubMed ID: 22566301
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery.
Visser M; van Venrooij LM; Vulperhorst L; de Vos R; Wisselink W; van Leeuwen PA; de Mol BA
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):511-8. PubMed ID: 22397879
[TBL] [Abstract][Full Text] [Related]
11. [Changes of skeletal muscle mass among disabled elderly].
Kimyagarov S; Levenkron S; Shabi A; Copel B
Harefuah; 2010 Feb; 149(2):67-70, 126. PubMed ID: 20549919
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and obesity.
Waters DL; Baumgartner RN
Clin Geriatr Med; 2011 Aug; 27(3):401-21. PubMed ID: 21824555
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey.
Bahat G; Saka B; Tufan F; Akin S; Sivrikaya S; Yucel N; Erten N; Karan MA
Aging Male; 2010 Sep; 13(3):211-4. PubMed ID: 20636235
[TBL] [Abstract][Full Text] [Related]
15. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.
Kato A; Ishida J; Endo Y; Takita T; Furuhashi M; Maruyama Y; Odamaki M
Nephrol Dial Transplant; 2011 Jun; 26(6):1967-76. PubMed ID: 20980356
[TBL] [Abstract][Full Text] [Related]
16. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of sarcopenia among nursing home older residents.
Landi F; Liperoti R; Fusco D; Mastropaolo S; Quattrociocchi D; Proia A; Russo A; Bernabei R; Onder G
J Gerontol A Biol Sci Med Sci; 2012 Jan; 67(1):48-55. PubMed ID: 21393423
[TBL] [Abstract][Full Text] [Related]
18. Size at birth, infant, early and later childhood growth and adult body composition: a prospective study in a stunted population.
Corvalán C; Gregory CO; Ramirez-Zea M; Martorell R; Stein AD
Int J Epidemiol; 2007 Jun; 36(3):550-7. PubMed ID: 17376801
[TBL] [Abstract][Full Text] [Related]
19. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women.
Aubertin-Leheudre M; Lord C; Goulet ED; Khalil A; Dionne IJ
Obesity (Silver Spring); 2006 Dec; 14(12):2277-83. PubMed ID: 17189556
[TBL] [Abstract][Full Text] [Related]
20. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
